(Bloomberg) The omicron variant threatens to widen an already yawning gap in access to Covid shots as scientists prepare for the possibility retooled vaccines will be needed and affluent countries race ahead once again.
(Oct 12): Moves by several countries to buy supplies of Merck & Co’s promising Covid pill before it’s even approved are raising concerns that some poorer nations could be left behind, in a repeat of the slow and inequitable rollout of vaccines.
(Bloomberg) Moves by a small group of countries to acquire supplies of Merck & Co.’s promising Covid pill before it’s even approved are raising concerns that some poorer nations could be left behind in a repeat of the slow and inequitable rollout of vaccines.